Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


How a controversial US drug policy could be harming cancer patients worldwide

Conceptual illustration showing drugs racing towards a finish line.

Illustration by Karol Banach

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Nature 620, 264-267 (2023)



  1. Miles, D. et al. Ann. Oncol. 32, 994–1004 (2021).

    Article  PubMed  Google Scholar 

  2. Parikh, R. B. et al. JAMA Oncol. 9, 567–569 (2023).

    Article  PubMed  Google Scholar 

  3. Belin, L., Tan, A., De Rycke, Y & Dechartres, A. Br. J. Cancer 122, 1707–1714 (2020).

    Article  PubMed  Google Scholar 

  4. Mooghali, M. et al. J. Clin. Oncol. 41, 1590 (2023).

    Article  PubMed  Google Scholar 

  5. Akhade, A., Sirohi, B. & Gyawali, B. Lancet Oncol. 23, 201–203 (2022).

    Article  PubMed  Google Scholar 

Download references


Latest on:

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links